Literature DB >> 16762582

Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains.

Simona Paraschiv1, Dan Otelea, Magdalena Dinu, Daniela Maxim, Mihaela Tinischi.   

Abstract

OBJECTIVE: To evaluate the prevalence of resistance mutations in the genome of HIV-1 F subtype strains isolated from Romanian antiretroviral (ARV) treatment-naïve patients and to assess the phylogenetic relatedness of these strains with other HIV-1 strains.
METHODS: Twenty-nine HIV-1 strains isolated from treatment-naïve adolescents (n=15) and adults (n=14) were included in this study. Resistance genotyping was performed by using Big Dye Terminator chemistry provided by the ViroSeq Genotyping System. The sequences of the protease and reverse transcriptase genes were aligned (ClustalW) and a phylogenetic tree was built (MEGA 3 software). For subtyping purposes, all the nucleotide sequences were submitted to the Stanford database.
RESULTS: All the studied strains were found to harbor accessory mutations in the protease gene. The most frequent mutation was M36I (29 of 29 strains), followed by L63T, K20R, and L10V. The number of polymorphisms associated with protease inhibitor resistance was different for the two age groups. Intraphylogenetic divergence was greater for adults than for adolescents infected in childhood. All the strains were found to belong to the F1 subtype. The phylogenetic analysis revealed that Romanian strains clustered together, but distinctly from F1 HIV-1 strains isolated in other parts of the world (Brazil, Finland, and Belgium).
CONCLUSION: Protease secondary mutations are present with high frequency in the HIV-1 F subtype strains isolated from Romanian ARV treatment-naïve patients, but no major resistance mutations were found.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762582     DOI: 10.1016/j.ijid.2005.11.006

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  10 in total

Review 1.  Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis.

Authors:  Sonya J Snedecor; Lavanya Sudharshan; Katherine Nedrow; Abhijeet Bhanegaonkar; Kit N Simpson; Seema Haider; Richard Chambers; Charles Craig; Jennifer Stephens
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-08       Impact factor: 2.205

2.  Correlation between resistance profile and immunosuppression in heavily treated HIV-1 infected Romanian patients.

Authors:  Loredana Manolescu; Aura Temereanca; Carmen Cristina Diaconu; Simona Ruta
Journal:  Rom Biotechnol Lett       Date:  2011-08

3.  Birth outcome in HIV vertically-exposed children in two Romanian centers.

Authors:  Ana Maria Tudor; Mariana Mărdărescu; Cristina Petre; Ruxandra Neagu Drăghicenoiu; Rodica Ungurianu; Cătălin Tilişcan; Dan Oţelea; Simona Claudia Cambrea; Doina Eugenia Tănase; Ana Maria Schweitzer; Simona Ruţă
Journal:  Germs       Date:  2015-12-02

4.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

5.  The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.

Authors:  Ivana Grgic; Snjezana Zidovec Lepej; Maja M Lunar; Mario Poljak; Adriana Vince; Ivana Baca Vrakela; Ana Planinic; Katja Seme; Josip Begovac
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-04       Impact factor: 2.205

6.  Transmitted HIV drug resistance in treatment-naive Romanian patients.

Authors:  Aura Temereanca; Luminita Ene; Sanjay Mehta; Loredana Manolescu; Dan Duiculescu; Simona Ruta
Journal:  J Med Virol       Date:  2013-04-16       Impact factor: 2.327

7.  Major HIV resistance mutations in untreated Romanian patients.

Authors:  A Temereanca; L Ene; D Duiculescu; S Ruta
Journal:  J Med Life       Date:  2011-05-25

8.  Interaction analysis of statistically enriched mutations identified in Cameroon recombinant subtype CRF02_AG that can influence the development of Dolutegravir drug resistance mutations.

Authors:  Sello Given Mikasi; Darren Isaacs; Rumbidzai Chitongo; George Mondide Ikomey; Graeme Brendon Jacobs; Ruben Cloete
Journal:  BMC Infect Dis       Date:  2021-04-23       Impact factor: 3.090

Review 9.  Romania, a Harbour of HIV-1 Subtype F1: Where Are We after 33 Years of HIV-1 Infection?

Authors:  Mădălina Preda; Loredana Cornelia Sabina Manolescu
Journal:  Viruses       Date:  2022-09-19       Impact factor: 5.818

10.  Polymorphisms and drug resistance analysis of HIV-1 isolates from patients on first line antiretroviral therapy (ART) in South-eastern Nigeria.

Authors:  Augustine O Udeze; David O Olaleye; Georgina N Odaibo
Journal:  PLoS One       Date:  2020-04-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.